α-Ketobenzothiazole Serine Protease Inhibitors of Aberrant HGF/c-MET and MSP/RON Kinase Pathway Signaling in Cancer.
about
Hepatocyte Growth Factor, a Key Tumor-Promoting Factor in the Tumor Microenvironment.The role of type II transmembrane serine protease-mediated signaling in cancer.The c-Met receptor: Implication for targeted therapies in colorectal cancer.Inhibition of pro-HGF activation by SRI31215, a novel approach to block oncogenic HGF/MET signaling.Targeting the tumor-promoting microenvironment in MET-amplified NSCLC cells with a novel inhibitor of pro-HGF activation.
P2860
α-Ketobenzothiazole Serine Protease Inhibitors of Aberrant HGF/c-MET and MSP/RON Kinase Pathway Signaling in Cancer.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
α-Ketobenzothiazole Serine Pro ...... e Pathway Signaling in Cancer.
@en
type
label
α-Ketobenzothiazole Serine Pro ...... e Pathway Signaling in Cancer.
@en
prefLabel
α-Ketobenzothiazole Serine Pro ...... e Pathway Signaling in Cancer.
@en
P2093
P2860
P356
P1433
P1476
α-Ketobenzothiazole Serine Pro ...... e Pathway Signaling in Cancer.
@en
P2093
Ben Y Owusu
Lidija Klampfer
Partha Karmakar
Peter K W Harris
Zhenfu Han
P2860
P304
P356
10.1002/CMDC.201500600
P577
2016-02-17T00:00:00Z